Valerie F. Cosson
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Population Pharmacokinetic and Exposure-Efficacy Analysis of Baloxavir Marboxil for Influenza Treatment and Post-Exposure Prophylaxis in Children.
Journal: Clinical pharmacology and therapeutics
Published: June 09, 2025
Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema.
Journal: Translational vision science & technology
Published: November 13, 2024
Ocular Pharmacokinetics of Faricimab Following Intravitreal Administration in Patients With Retinal Disease.
Journal: Translational vision science & technology
Published: November 13, 2024
Pharmacokinetic characterization and exposure-response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria.
Journal: British journal of clinical pharmacology
Published: September 05, 2024
Simulation-based evaluation of the Pharmpy Automatic Model Development tool for population pharmacokinetic modeling in early clinical drug development.
Journal: CPT: pharmacometrics & systems pharmacology
Published: December 22, 2023
The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy.
Journal: Neurology and therapy
Published: September 11, 2023
A Pharmacokinetics-Time to Alleviation of Symptoms Model to Support Extrapolation of Baloxavir Marboxil Clinical Efficacy in Different Ethnic Groups with Influenza A or B.
Journal: Clinical pharmacology and therapeutics
Published: December 09, 2021
Pharmacokinetics, safety, and simulated efficacy of an influenza treatment, baloxavir marboxil, in Chinese individuals.
Journal: Clinical and translational science
Published: October 25, 2021
A Baseline Score to Predict Response to Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration.
Journal: Translational vision science & technology
Published: June 10, 2021
Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: January 07, 2021
How Semiphysiological Population Pharmacokinetic Modeling Incorporating Active Hepatic Uptake Supports Phase II Dose Selection of RO7049389, A Novel Anti-Hepatitis B Virus Drug.
Journal: Clinical pharmacology and therapeutics
Published: November 05, 2020
What drives the dynamics of HBV RNA during treatment?
Journal: Journal of viral hepatitis
Published: July 02, 2020
Last Updated: 09/26/2026